NL-OMON50414招募中不适用
The *RADIANCE-HTN* Study A study of the ReCor Medical Paradise System in Clinical Hypertension - RADIANCE-HTN Study
ReCor Medical BV0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Documented history of essential hypertension
排除标准
- •Main renal artery diameter < 3.5 mm and > 8 mm,TRIO cohort only (enrolment SOLO
- •cohort completed)
- •Main renal artery length < 25 mm, TRIO cohort only (enrolment SOLO cohort
研究者
相似试验
进行中（未招募）
不适用
A Study of the ReCor Medical Paradise System in Clinical HypertensionVascular DiseasesHypertensionNCT02649426ReCor Medical, Inc.282
招募中
Unknown
A retrospective study on radiation exposure of medical staff during fluoroscopic endoscopyRadiation exposureJPRN-UMIN000050554Shimane University50
招募中
不适用
The Radiance ll Pivotal Study - A Study of the ReCor Medical Paradise System in Stage ll Hypertensiohypertension - high blood pressure10057166NL-OMON55721ReCor Medical B.V.20
进行中（未招募）
1 期
A Randomized Phase II Study Of Reirradiation And Hyperthermia Versus Reirradiation And Hyperthermia Plus Chemotherapy For Locally Recurrent Breast Cancer In Previously Irradiated Area - RehypciAll patients with a local regional recurrence of invasive breast cancer in previously irradiated area with measurable lesions not suitable for resection are eligible for this trial. Patients with metastases are allowed if their life expectancy is considered 1 year or more, i.e. a limited bone metastases.MedDRA version: 12.1Level: LLTClassification code 10008456Term: Chemotherapy single agent systemicEUCTR2010-019225-33-NL104
已完成
2 期
A Randomized Phase II Study Of Reirradiation And Hyperthermia Versus Reirradiation And Hyperthermia Plus Chemotherapy For Locally Recurrent Breast Cancer In Previously Irradiated Areabreast carcinoma10006291Breast cancerNL-OMON34632Academisch Medisch Centrum104